Article Details
Retrieved on: 2025-02-07 14:04:53
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the effectiveness of certain biotech antiviral drugs and monoclonal antibody therapies, such as nirmatrelvir/ritonavir and sotrovimab, in reducing mortality and hospitalization due to the SARS-CoV-2 Omicron variant, highlighting key developments in COVID-19 drug research.
Article found on: www.pulmonologyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here